doi: 10.3389/fphar.2025.1656541 Received 30 June 2025 Accepted 25 July 2025 Published 13 October 2025 Volume 16 - 2025 Edited by Karim Hosni, Institut National de Recherche et d'Analyse Physico-Chimique (INRAP), Tunisia Reviewed by Tansel Sapmaz, University of Health Sciences, Trkiye Chengniu Wang, Nantong University, China Updates Copyright 2025 AbdAllah, Eid, Hussein, Abou khalil, Ragab, Wahman, Almohaimeed, Moneeb, Abdel-Tawab, Mohammedsaleh, Barnawi and Waly
Here is what the numbers show
Benefits of L-Carnitine and Taurine By: Holly L
These restrictions help reduce the risk that compounders will prepare these unapproved drug products for patients whose medical needs could be met by an approved product
This distinction matters because exogenous GH administration carries a different risk profile than peptide-stimulated endogenous release
F.HorsagerJ.et al (2021)